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Academy of Sciences of the Czech Republic, Prague, Czech RepublicABSTRACT Phosducin (Pdc), a highly conserved phosphoprotein, plays an important role in the regulation of G protein
signaling, transcriptional control, and modulation of blood pressure. Pdc is negatively regulated by phosphorylation followed
by binding to the 14-3-3 protein, whose role is still unclear. To gain insight into the role of 14-3-3 in the regulation of Pdc function,
we studied structural changes of Pdc induced by phosphorylation and 14-3-3 protein binding using time-resolved fluorescence
spectroscopy. Our data show that the phosphorylation of the N-terminal domain of Pdc at Ser-54 and Ser-73 affects the structure
of the whole Pdc molecule. Complex formation with 14-3-3 reduces the flexibility of both the N- and C-terminal domains of phos-
phorylated Pdc, as determined by time-resolved tryptophan and dansyl fluorescence. Therefore, our data suggest that phos-
phorylated Pdc undergoes a conformational change when binding to 14-3-3. These changes involve the Gtbg binding
surface within the N-terminal domain of Pdc, and thus could explain the inhibitory effect of 14-3-3 on Pdc function.INTRODUCTIONPhosducin (Pdc), a highly conserved acidic phosphoprotein,
regulates visual signal transduction by modulating the
amount of transducin Gtabg heterotrimer through competi-
tion with the Gta subunit for binding to the Gtbg complex
(1,2). Pdc was also suggested to be involved in transcrip-
tional control through its interaction with a transcription
factor Crx (3) and in the regulation of transmission at
the photoreceptor-to-ON-bipolar cell synapse (4). Many
members of the Pdc family (Pdc-like proteins) are known
to act as cochaperons and assist in the folding of a variety
of proteins (5). Recently, it was shown that Pdc regu-
lates the cardiovascular system by modulating sympathetic
activity and blood pressure, and thus represents a potential
target for the treatment of stress-dependent hypertension
(6,7). However, the mechanism of this modulation is
unknown.
The crystal structure of Pdc bound to the Gtbg complex
revealed that Pdc consists of two separate domains that
wrap around Gtbg to form an extensive interface (8,9).
The N-terminal domain of bound Pdc is mostly helical
and interacts with the portion of the Gta binding surface
of the Gtbg complex, whereas the C-terminal domain pos-
sesses a thioredoxin-like fold and interacts with the Gtbg
surface implicated in membrane binding (Fig. 1 A). The
ability of Pdc to bind to the Gtbg complex depends strongly
on its phosphorylation state (10,11). Whereas the un-
phosphorylated Pdc binds the Gtbg complex tightly, the
phosphorylation of several serine residues within the
N-terminal domain reduces its binding affinity through aSubmitted May 18, 2012, and accepted for publication September 19, 2012.
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0006-3495/12/11/1960/10 $2.00mechanism that is still unclear. The in vitro experiments
showed that the cAMP-dependent protein kinase (PKA)
phosphorylates Pdc at Ser-73, and the Ca2þ/calmodulin-
dependent protein kinase (CaMKII) phosphorylates Ser-6,
Ser-36, Ser-54, Ser-73, and Ser-106 (10,12,13). However,
the phosphorylation at just Ser-54 and Ser-73 has been
shown to be essential for inhibiting Pdc function in vivo
in a process that involves Pdc binding to the regulatory
14-3-3 protein (10,11,14).
The 14-3-3 proteins are highly conserved dimeric mole-
cules that regulate the function of other proteins through
a number of different mechanisms (15,16). The 14-3-3
proteins recognize specific phosphoserine/phosphothreo-
nine-containing motifs, and many 14-3-3 binding partners
contain two or more such motifs (17–19). The dimeric
nature of the 14-3-3 proteins enables simultaneous engage-
ment of two binding motifs and hence the efficient structural
modulation of bound ligand and/or the masking of its func-
tional site (20,21). It has been shown that in intact retina the
simultaneous phosphorylation of both Ser-54 and Ser-73 is
required for a dramatic reduction of Pdc binding to Gtbg,
most likely as a result of the competing interaction between
the 14-3-3 protein and phosphorylated Pdc (10–13). The
ability of the 14-3-3 proteins to interfere with protein-
protein or protein-DNA interactions of their binding part-
ners is well established. For example, such a mode of
regulation was shown for the Bcl-2 family member BAD
(22), the regulator of G protein signaling 3 (23,24), and fork-
head transcription factor FOXO4 (25). In all of these cases,
the 14-3-3 protein either sterically occludes and/or affects
the structure of its binding partners. The exact role of the
14-3-3 protein in regulating Pdc function is still unclear,
but it is entirely possible that similar mechanisms arehttp://dx.doi.org/10.1016/j.bpj.2012.09.021
FIGURE 1 (A) Schematic representation of the primary structure of Pdc.
Red vertical bars denote locations of the 14-3-3 protein binding motifs.
Yellow bars denote locations of single Cys residues used as sites for
AEDANS attachment. The green bar denotes the location of a single tryp-
tophan residue, Trp-29. (B) Ribbon representation of the Pdc:Gtbg complex
structure (8,9). The N-terminal domain of Pdc is show in green, and the
C-terminal domain is shown in light brown. Residues Ser-54 and Ser-73
(phosphorylation sites) are shown in red, Cys residues (AEDANS attach-
ment sites) are shown in yellow, and tryptophan residue Trp-29 is shown
in light green.
Structural Modulation of Phosducin by 14-3-3 1961involved because both putative 14-3-3 binding motifs are
located within the N-terminal domain, which participates
in Gtbg binding (Fig. 1 A) (8,9). In addition, the possibility
that the 14-3-3 protein may also modulate interactions
between Pdc and its other binding partners, such as CRX
and SUG1 (3,10,26), cannot be ruled out.
To gain insight into the role of 14-3-3 in regulating
Pdc function, we used time-resolved fluorescence spectros-
copy, analytical ultracentrifugation (AUC), and dynamic
light scattering (DLS) to investigate the structural changes
of Pdc induced by phosphorylation and 14-3-3 protein
binding.MATERIALS AND METHODS
Expression, purification, and phosphorylation
of Pdc
The DNA encoding rat Pdc (a kind gift of Dr. D.C. Klein, National
Institutes of Health) was ligated into pET-15b (Novagen) using the NdeI
and BamHI sites. All mutants of Pdc were generated using the Quik-
Change kit (Stratagene). All mutations were confirmed by sequencing.
The N-terminally histidine-tagged protein was expressed by isopropyl
b-D-1-thiogalactopyranoside induction for 20 h at 25C, and purified
from Escherichia coli BL21(DE3) cells using Chelating Sepharose Fast
Flow (GE Healthcare Life Sciences) according to the standard protocol.
Eluted Pdc was dialyzed against buffer containing 50 mM Tris-HCl
(pH 8), 20 mM NaCl, 2 mM EDTA, and 5 mM dithiothreitol (DTT),
and purified by anion-exchange chromatography on a Q-Sepharose column
(GE Healthcare Life Sciences). The protein was eluted using a lineargradient of NaCl (from 50 to 1000 mM) and concentrated to 10 mg/ml.
The final step, size-exclusion chromatography on a Superdex 200 column
(GE Healthcare Life Sciences), was performed in buffer containing 20 mM
Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 5 mM DTT, and 10%
(w/v) glycerol.
Purified Pdc was phosphorylated by incubation (1 h at 30C and then
15 h at 7C) with 120 U of PKA (Promega) per milligram of protein in
the presence of 0.75 mM ATP and 15 mM MgCl2. The reaction was
stopped by dialysis against the buffer containing 20 mM Tris-HCl (pH
7.5), 200 mM NaCl, 1 mM EDTA, 5 mM DTT, and 10% (w/v) glycerol.
The completeness of the phosphorylation reaction was checked by matrix-
assisted laser desorption ionization time of flight (MALDI-TOF) mass spec-
trometry (MS).Labeling of Pdc mutants by 1,5-IAEDANS
Covalent modification of Pdc mutants containing a single cysteine residue
(at positions 89, 97, 148, 157, or 168) with the thiol-reactive probe
5-((((2-iodoacetyl)amino)ethyl)amino)naphthalene-1-sulfonic acid (1,5-
IAEDANS) was carried out as described elsewhere (24,25). See the Sup-
porting Material for more details.Expression and purification of the 14-3-3 protein
The 14-3-3 protein wild-type (human isoform z), the C-terminally truncated
version 14-3-3DC (residues 1–230 with deleted disordered C-terminal
loop), and the mutant version 14-3-3noW containing no tryptophan residues
(mutations Trp59Phe and Trp228Phe) were prepared as described previ-
ously (27,28).MS analysis of Pdc
Samples of unphosphorylated or phosphorylated Pdc were first separated by
15% SDS-PAGE, and excised protein bands were digested with trypsin en-
doprotease (Promega) directly in gel after destaining and cysteine modifica-
tion by iodoacetamide (29). The resulting peptide mixtures were extracted
and loaded onto the MALDI-TOF target with 2,5-dihydroxybenzoic acid
as the matrix. Positively or negatively charged spectra or LIFT MS/MS
measurements were acquired with an UltraFLEX III mass spectrometer
(Bruker-Daltonics, Bremen, Germany).AUC
Sedimentation equilibrium and sedimentation velocity experiments were
performed using a ProteomeLab XL-I Beckman Coulter analytical ultra-
centrifuge equipped with an AN50Ti rotor. Samples were dialyzed against
buffer containing 20 mM Tris-HCl (pH 7.5), 200 mM NaCl, and 2 mM
2-mercaptoethanol before analysis. The buffer density, viscosity, and par-
tial specific volume of all proteins were estimated using the program
SEDNTERP 1.09 (http://www.jphilo.mailway.com). Data analysis was per-
formed with the SEDFITand SEDPHAT packages (30,31). See the Support-
ing Material for more details.DLS
DLS measurements were carried out as described previously (32). See the
Supporting Material for more details.Time-resolved fluorescence measurements
Fluorescence intensity and anisotropy decays were measured on a time-
correlated single photon counting apparatus comprised of a femtosecondBiophysical Journal 103(9) 1960–1969
1962 Rezabkova et al.Ti:Sapphire laser with repetition rate reduced to 4 MHz (Chameleon Ultra
II and Pulse Picker HP; Coherent) and time-correlated single photon
counting detection with a cooled MCP PMT (R3809U-50; Hamamatsu).
AEDANS fluorescence was excited at the 355 nm by a second harmonic
of the Ti:Sapphire laser generating at 710 nm. Tryptophan emission was
excited at 298 nm by a third harmonic of the laser emitting at 894 nm.
AEDANS and Trp fluorescence was collected at 480 and 355 nm using
a monochromator equipped with a 400 nm cutoff and UG1 glass filter
(Zeiss), respectively, placed in front of its input slit. Typically, the curves
were accumulated in 1024 channels until 107 counts per decay were reached
with time resolution of 200 or 50 ps per channel for dansyl and tryptophan
emissions, respectively. Samples were placed in a thermostatic holder, and
all experiments were performed at 22C in a buffer containing 20 mM Tris-
HCl (pH 7.5), 200 mM NaCl, 1 mM EDTA, and 2 mM 2-mercaptoethanol.
The Pdc concentration was 30 mM, and the 14-3-3 protein concentration
was 60 mM.
The fluorescence decays were acquired under magic-angle conditions in
which the measured intensity decay, I(t), is independent of the rotational
diffusion of the chromophore. Fluorescence was assumed to decay multiex-
ponentially according to the formula
IðtÞ ¼
X
i
ai  exp
t
ti

(1)
where ti and ai are the fluorescence lifetimes and the corresponding ampli-
tudes, respectively. A maximum entropy method was used to analyze I(t)
(33). The program yields amplitudes, ai, that represent the lifetime distribu-
tion. We chose 100 lifetimes equidistantly spaced in the logarithmic scale,
covering the range from 20 ps to 20 ns for tryptophan, and 50 ps to 50 ns for
dansyl. The mean lifetime was calculated as follows:
tmean ¼
X
i
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P
i

ait
2
i

P
i
ðaitiÞ (2)
where fi is the fractional intensity of the ith lifetime component.
The polarized components Ijj(t) and It(t)were accumulated quasi-simul-
taneously with a switching frequency of 30 s. The polarized decays were
measured with the emission polarizer set in the fixed vertical position,
and excitation polarization plane was rotated 0 and 90, respectively.
This approach minimized the need to correct transmittances of the detection
channel for different polarizations, because the G-factor was close to one.
The value of the G-factor was determined by an independent experiment.
The fluorescence anisotropy decays r(t) were obtained by simultaneous re-
convolution analysis of both parallel Ijj(t) and perpendicular It(t) decay
components. Data were analyzed by a model-independent maximum
entropy method approach that does not set prior limits on the shape of
the distributions (33). The anisotropies r(t) were analyzed for a series of
exponentials:
rðtÞ ¼
X
i
bi  exp
t
fi

(3)
where the amplitudes bi represent the distribution of the correlation times fi
and are related to the initial anisotropy r0 by the formula
X
i
bi ¼ r0 (4)
We used 100 correlation times fi equidistantly spaced in the logarithmic
scale ranging from 50 ps to 200 and 500 ns for tryptophan and AEDANS,
respectively.Biophysical Journal 103(9) 1960–1969RESULTS
Preparation of Pdc simultaneously
phosphorylated at Ser-54 and Ser-73
It has been suggested that Pdc possesses two 14-3-3 protein
binding motifs containing phosphorylation sites Ser-54 and
Ser-73 (Fig. 1). Residue Ser-54 is known to be phosphory-
lated by CaMKII, whereas Ser-73 is a substrate for PKA
(10,12,13). The preparation of milligram quantities of Pdc
stoichiometrically phosphorylated at both Ser-54 and Ser-
73 (denoted as dpPdc) turned out to be very difficult, mainly
due to the relatively low activity of CaMKII. Therefore, to
prepare a sufficient amount of dpPdc for biophysical studies,
we mutated residue Gln-52 to Lys, thereby making residue
Ser-54 a substrate for PKA. The Pdc(Gln52Lys) mutant
was expressed, purified, and phosphorylated by PKA, and
the result of the phosphorylation reaction was determined
via in-gel trypsin digestion followed by MALDI-TOF MS.
The comparison of the received mass spectra of digested
samples with theoretically generated peptides confirmed
the expression of the N-terminally His-tagged full-length
Pdc construct with cleaved N-terminal methionine. The
positive MS data for the phosphorylated Pdc after the
trypsin digestion revealed signal at m/z 1000.45 correspond-
ing to the peptide with sequence KMpSSPQSR, and its
MS/MS spectrum in negative mode confirmed the phospho
moiety on Ser-54. On the other hand, the positive MS
signal at 792.34 was detected in unphosphorylated Pdc
(sequence MSSPQSR), and no peak was found at m/z
1000.45. The phosphorylation of Ser-73 was determined
by two positive signal at m/z 2701.27 and 2829.27 corre-
sponding to sequences KMpSIQEYELIHQDKEDEGCLR
and KMpSIQEYELIHQDKEDEGCLRK, respectively. The
MS/MS spectrum in negative mode revealed the phospho-
group on Ser-73 and carbamidomethyl modification of
Cys-89. The positive MS signal at 2493.29 was detected in
the unphosphorylated sample (sequence MSIQEYELIHQD
KEDEGCLR), and no peak corresponding to phosphorylated
peptide was found.Biophysical characterization of dpPdc:14-3-3
complex
We used AUC to perform a basic biophysical characteriza-
tion of the interaction between dpPdc and the dimeric 14-
3-3 protein. Initial sedimentation equilibrium experiments
revealed that an apparent dissociation constant (KD) of
a complex between doubly phosphorylated dpPdc and 14-
3-3 wild-type (human isoform z) is in the micromolar range,
suggesting a weak transient interaction (34). To prepare
a more stable dpPdc:14-3-3 complex suitable for biophys-
ical analysis, we decided to use in all our experiments
(AUC, DLS, and fluorescence measurements) the 14-3-3
protein deleted of its C-terminal 15 residues. This region
Structural Modulation of Phosducin by 14-3-3 1963is disordered in all available crystal structures of the 14-3-3
proteins, presumably due to its high flexibility, and seems to
function as an autoinhibitor of 14-3-3–ligand interactions
(27,35,36). For example, a similar approach was used by
Ottmann et al. (37) to stabilize the interaction between 14-
3-3 and plant plasma membrane Hþ-ATPase.
The sedimentation equilibrium measurements were used
to estimate KD. Fig. 2 A shows an example of sedimentation
equilibrium profiles at 280 nm for a mixture of 14-3-3 and
dpPdc. The obtained data were best analyzed in terms of
a reversible dpPdc þ 14-3-3 dimer# dpPdc:14-3-3 (with
a 1:2 molar ratio) equilibrium to yield KD of 3 5 0.5 mM.
Next, the sedimentation velocity measurements were used
to study the importance of the simultaneous phosphoryla-
tion of Ser-54 and Ser-73 for the interaction between Pdc
and 14-3-3. The continuous sedimentation coefficient distri-FIGURE 2 AUC analysis. (A) Example of sedimentation equilibrium profiles
speeds and different mixing ratio of proteins and dilution series). Symbols corr
26,000 (blue triangles) rpm. The lines through the data represent this best-fit anal
dpPdc þ 14-3-3 dimer# dpPdc:14-3-3 (with a 1:2 molar ratio) equilibrium a
sedimentation coefficient distributions, c(s), for the 14-3-3 dimer alone (black
and dpPdc and 14-3-3 mixed in the molar ratio 1:1 (green) are shown. (C) Sedim
ficient distributions, c(s), for dpPdc and 14-3-3 mixed in the molar ratio 1:2 (blac
1:2 (blue), and pPdc singly phosphorylated at Ser-73 and 14-3-3 mixed in the mbutions, c(s), obtained from these experiments are shown in
Fig. 2, B and C. Analysis of the distributions reveals that the
14-3-3 protein and doubly phosphorylated dpPdc form a
complex with a weight-averaged sedimentation coefficient
(sw) of 4.0 S (Fig. 2 B), whereas the 14-3-3 protein and
dpPdc alone show single peaks with sw values of 3.7 and
2.4 S, respectively. The sedimentation velocity experiments
also confirmed the 1:2 stoichiometry of the dpPdc:14-3-3
complex. When dpPdc and 14-3-3 were mixed in a 1:2
molar ratio (30 mMdpPdc, 60 mM14-3-3), the sedimentation
coefficient distribution revealed only one peak at sw of 4.0 S.
However, when the proteins were mixed in a 1:1 molar
ratio (60 mM dpPdc, 60 mM 14-3-3), the distribution con-
tained two peaks at sw of ~2 and ~4 S, suggesting an equi-
librium between free dpPdc and the dpPdc:14-3-3 (1:2)
complex (Fig. 2B). The analysis of samples containing singlyat 280 nm for a mixture of 14-3-3 and dpPdc from a global fit (different
espond to data collected at 8000 (black squares), 15,000 (red circles), and
ysis. Residuals corresponding to the best-fit analysis in terms of a reversible
re shown. (B) Sedimentation velocity analysis. The normalized continuous
), Pdc alone (red), dpPdc and 14-3-3 mixed in the molar ratio 1:2 (blue),
entation velocity analysis. The normalized continuous sedimentation coef-
k), pPdc singly phosphorylated at Ser-54 and 14-3-3 mixed in the molar ratio
olar ratio 1:2 (red) are shown.
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pPdc(pS73)) revealed sedimentation coefficient distributions
containing peaks that correspond to free pPdc (sw of 1.9 S)
and 14-3-3 (sw of 3.5 S), thus suggesting either no or very
weak interaction (Fig. 2 C). Therefore, these data confirm
that the simultaneous phosphorylation of both Ser-54 and
Ser-73 is required for the 14-3-3 protein binding to Pdc, in
agreement with previous reports (10,11,14).DLS measurements
The small difference in sw between the dpPdc:14-3-3 com-
plex and the 14-3-3 protein dimer alone, as revealed by
sedimentation velocity experiments, indicates that the two
particles have similar hydrodynamic properties (Fig. 2 B).
To check this hypothesis, we determined the hydrodynamic
radii (RH) of Pdc, dpPdc, the 14-3-3 dimer, and the
dpPdc:14-3-3 complex by DLS. The obtained hydrody-
namic radii are summarized in Table 1. The small difference
in RH between the 14-3-3 dimer alone and the dpPdc:14-3-3
complex (37 and 44 A˚, respectively) is consistent with
the results of the sedimentation velocity experiments. This
may suggest that in the complex, the molecule of dpPdc
is located within the central channel of the cup-shaped
14-3-3 dimer (Fig. S1), and thus the resulting complex
would display similar hydrodynamic properties as the 14-
3-3 protein dimer alone. In addition, although the 14-3-3
protein dimer shows a relative molecular mass (Mr) ~2-
fold greater than that of Pdc (Mr(14-3-3 dimer) ¼ 57120;
Mr(Pdc) ¼ 30300), the RH values of Pdc alone and the
14-3-3 protein dimer were found to be essentially the
same (~37 A˚). This suggests that the shape of the Pdc mole-
cule is significantly more asymmetric than that of 14-3-3.
The extended conformation of Pdc is also evident from
the higher ratio between the experimental and theoretical
RH values compared with the 14-3-3 protein dimer (theoret-
ical values were calculated assuming spherical proteins
with the corresponding molecular masses and without
hydration). It was previously suggested that the N-terminal
domain of Pdc is disordered and highly flexible (8,38).
Thus, the observed asymmetric shape of the Pdc molecule
may result from the disordered nature of the N-terminal
domain. The high flexibility of the Pdc structure is also
consistent with the higher proteolytic sensitivity of Pdc
compared with 14-3-3 (Fig. S2).TABLE 1 Hydrodynamic radii of proteins from DLS experiments
RH (A˚) 14-3-3 Pdc
DLS* 36.65 0.5 37.45 0.3
Theoreticaly 25.4z 20.6
*Values are the mean5 SD of five measurements in buffer containing 20 mM
yTheoretical RH of a spherical rigid protein molecule without hydration estimate
[g/mol] (43).
zThe 14-3-3 protein forms dimers (Mr ¼ 57120).
xAssuming the dpPdc:14-3-3 complex with a 1:2 molar stoichiometry.
Biophysical Journal 103(9) 1960–1969Time-resolved tryptophan fluorescence of Trp29
shows a 14-3-3 protein-induced structural change
at the N-terminus of Pdc
The sequence of Pdc contains only one tryptophan residue,
Trp-29 (Fig. 1), that is located (as shown by the crystal
structure of the Pdc:Gtbg complex) in close proximity to
both phosphorylation sites Ser-54 and Ser-73 (38) and the
SUMOylation site Lys-33 (39). Thus, we used the time-
resolved fluorescence intensity and anisotropy decay mea-
surements of Trp-29 to study structural changes in this
important regulatory region of Pdc molecule. The human
14-3-3znoW protein mutant missing all Trp residues (muta-
tions Trp59Phe and Trp228Phe) was used in all Pdc tryp-
tophan measurements. We previously showed that these
two mutations have no effect on the binding properties of
the 14-3-3z protein (27,28,36). We analyzed the time-
resolved fluorescence intensity and anisotropy decays using
a singular-value decomposition maximum entropy method
as previously described (33). The indole moiety, even in
proteins that contain a single Trp residue, frequently ex-
hibits complicated multiexponential decays, and a detailed
interpretation of particular decay components is often im-
possible (40,41). Therefore, we used a mean fluorescent life-
time (tmean) as a robust qualitative indicator of changes in
the polarity (and/or the quenching interactions) in the Trp-
29 microenvironment (Table 2). It can be seen that although
the phosphorylation of Pdc at Ser-54 and Ser-73 by itself
has no effect on tmean of Trp-29, the 14-3-3 protein binding
to dpPdc caused a significant increase in tmean, suggest-
ing structural changes in the vicinity of Trp-29 upon the
complex formation. We studied the segmental motion of
Trp-29 using the polarized time-resolved emission measure-
ments. The results of these experiments are presented in
Table 2 and Fig. 3. The fluorescence anisotropy decay of
Trp-29 reveals three classes of correlation times. Short
correlation times located around 0.4–0.5 ns and 1.8–2.7 ns
reflect the fast local motion of Trp-29. The third correlation
time, f3, likely reflects the rotational diffusion of the whole
protein molecule. For comparison with the DLS data,
we included the calculated hydrodynamic radius estimated
from f3. A comparison of RH from Tables 1 and 2 reveals
that the radius obtained from both experiments agree nicely,
being 34 A˚ and 43 A˚ for dpPdc (Pdc) and the dpPdc:14-
3-3 complex, respectively. This observation independentlydpPdc 14-3-3 þ Pdc 14-3-3 þ dpPdc
38.25 0.5 36.95 0.1 44.25 0.6
20.6 29.3x
Tris-HCl (pH 7.5), 1 mM EDTA, 150 mM NaCl, and 5 mM DTT.
d from the equation RH [m] ¼ 661012M1/3, whereM is a molecular mass
TABLE 2 Summary of time-resolved tryptophan fluorescence measurements of Pdc(W29)
Sample tmean*
,y (ns) b1** f1
jj (ns) b2** f2
jj (ns) b3** f3
jj (ns) RH
z (A˚)
Pdc 3.9 0.045 0.5 0.094 2.4 0.061 36 34
Pdc þ 14-3-3x 3.9 0.051 0.5 0.088 2.4 0.062 61 41
dpPdc 3.8 0.057 0.4 0.102 2.7 0.043 36 34
dpPdc þ 14-3-3 4.2 0.028 0.4 0.067 1.8 0.108 71 43
*SD > 0.05 ns.
yThe mean fluorescent lifetime (tmean) was calculated using Eq. 2.
zThe hydrodynamic radius RH was estimated from the equation f3 ¼ hV=kT, where h is water viscosity, T is temperature, k is the Boltzmann constant, and V
is volume of the spherical rigid rotor ðV ¼ 4=3pR3HÞ.xThe human 14-3-3noW protein mutant missing all Trp residues (mutations Trp59Phe and Trp228Phe) was used in all Pdc tryptophan measurements
(27,28,36).
jjSD < 20%.
**SD < 0.01.
Structural Modulation of Phosducin by 14-3-3 1965supports the hypothesis that dpPdc molecule docks to
the central channel of the 14-3-3 dimer upon complex
formation.FIGURE 3 Fluorescence anisotropy decays of Trp-29 constructed from
the raw polarized decay data for phosphorylated dpPdc (A) and unphos-
phorylated Pdc (B). Open circles (B) belong to decays in the absence
of the 14-3-3 protein; solid circles (C) represent decays in the presence
of the 14-3-3 protein. Solid lines are emission anisotropies calculated
from the best least-squares fits of polarized decays.The change in the segmental motion of Trp-29 was as-
sessed from the change in the sum of amplitudes of fast
anisotropy decay components bshort (bshort ¼ b1 þ b2).
Whereas the phosphorylation by itself seems to somewhat
increase the segmental motion of Trp-29 (bshort(Pdc) ¼
0.139; bshort(dpPdc) ¼ 0.159), the 14-3-3 protein binding
substantially decreases its segmental motion in dpPdc
(bshort(dpPdc þ 14-3-3) ¼ 0.095). This is also well demon-
strated by the significantly elevated anisotropies at long
times after the excitation at Fig. 3 A. These data suggest
that the binding of 14-3-3 protein significantly reduces the
flexibility of dpPdc in the region surrounding Trp-29,
presumably through direct physical contact.Mapping of interactions between dpPdc and the
14-3-3 protein using time-resolved dansyl
fluorescence
The AEDANS moiety is an environmentally sensitive
extrinsic fluorophore that is often used to map the binding
interfaces in protein complexes and to study the conforma-
tional dynamics of protein molecules (24,25,42). In this
study, we used the time-resolved fluorescence intensity and
anisotropy decay measurements of AEDANS-labeled Pdc
mutants to investigate the structural changes of Pdc and
map its binding interface with the 14-3-3 protein. The
AEDANS was covalently attached to a single cysteine
residue of five different Pdc mutants to sample various
regions of the Pdc molecule (Fig. 1). The first two residues,
Cys-89 and Cys-97, are located within the N-terminal
domain of Pdc, whereas residues Cys-148, Cys-157, and
Cys-168 are located within its C-terminal domain. The
time-resolved fluorescence intensity measurements revealed
that all AEDANS-labeled Pdc mutants exhibited complex
emission decays with multimodal lifetime distributions.
Therefore, variations in the tmean of AEDANS were used to
monitor changes in the solvent exposure (polarity) of labeled
Pdc surfaces upon phosphorylation and 14-3-3 protein
binding (Table 3 and Fig. 4). The phosphorylation of Ser-
54 and Ser-73 decreased the tmean of all AEDANS-labeledBiophysical Journal 103(9) 1960–1969
TABLE 3 Summary of time-resolved fluorescence measurements of AEDANS-labeled single-cys mutants of Pdc
Pdc mutant tmean*
,y (ns) b1
x f1
z (ns) b2
x f2
z (ns) b3
x f3
z (ns) b4
x f4 (ns)
Cys-89 Not-P 15.00 0.027 0.4 0.093 2.5 0.078 13 0.032 > 50
þ 14-3-3 15.01 0.044 0.5 0.093 3.0 0.068 16 0.025 > 50
P 14.67 0.029 0.4 0.092 2.1 0.066 8 0.043 > 50
þ 14-3-3 15.52 0.013 0.3 0.076 2.1 0.066 9 0.075 > 50
Cys-97 Not-P 15.28 0.054 0.5 0.083 3.3 0.056 12 0.037 > 50
þ 14-3-3 15.28 0.035 0.4 0.090 2.5 0.059 11 0.046 > 50
P 14.73 0.052 0.5 0.096 2.5 0.066 15 0.016 > 50
þ 14-3-3 15.33 0.052 0.5 0.076 3.3 0.055 15 0.047 > 50
Cys-148 Not-P 15.70 0.006 0.3 0.088 2.7 0.071 12 0.065 > 50
þ 14-3-3 15.51 0.022 0.5 0.077 3.0 0.074 12 0.057 > 50
P 14.99 0.023 0.4 0.078 2.5 0.084 11 0.045 > 50
þ 14-3-3 15.14 0.011 0.3 0.075 2.1 0.083 10 0.061 > 50
Cys-157 Not-P 14.70 0.023 0.5 0.094 3.0 0.096 18 0.017 > 50
þ 14-3-3 14.69 0.034 0.7 0.080 2.7 0.100 19 0.016 > 50
P 14.13 0.045 0.6 0.100 3.3 0.071 18 0.014 > 50
þ 14-3-3 14.32 0.038 0.4 0.124 3.0 0.034 23 0.034 > 50
Cys-168 Not-P 15.43 0.032 0.6 0.109 2.7 0.079 25 0.010 > 50
þ 14-3-3 15.42 0.029 0.5 0.099 2.7 0.087 18 0.015 > 50
P 14.92 0.047 0.5 0.098 2.7 0.075 15 0.010 > 50
þ 14-3-3 15.44 0.022 0.3 0.096 2.7 0.071 18 0.041 > 50
*SD > 0.05 ns.
yThe mean fluorescent lifetime (tmean) was calculated using Eq. 2.
zSD < 20%.
xSD < 0.01.
1966 Rezabkova et al.Pdc mutants, suggesting an increase in the polarity and/or
the quenching interactions around the AEDANS moieties
(Fig. 4 A). The largest decrease in tmean upon phosphory-
lation was observed for the Pdc mutant containing Cys
residue at position 148 within the C-terminal domain. The
observed changes in tmean of all AEDANS-labeled Pdc
mutants also suggest that both domains of Pdc interact with
each other, and thus a posttranslational modification within
the N-terminal domain can affect the structure in the
C-terminal domain. The 14-3-3 protein binding to dpPdc,
on the other hand, had an opposite effect on the tmean of all
AEDANS-labeled Pdc mutants, with the largest increase
observed for mutants dpPdc(Cys89), dpPdc(Cys97), and,
interestingly, also for dpPdc(Cys168) (Fig. 4 B). Thus, bind-
ing of the 14-3-3 protein significantly affects the microen-
vironment around the AEDANS moieties not only in the
N-terminal domain of dpPdc, where both phosphorylation
sites and 14-3-3 binding motifs are located, but also in the
C-terminal domain, suggesting a direct physical contact
between 14-3-3 and the C-terminal domain of dpPdc.
It is easy to envisage that the close proximity of the
AEDANS moiety and 14-3-3 upon complex formation and/
or the phosphorylation- and the 14-3-3 protein binding-
induced structural change of AEDANS-labeled dpPdc seg-
ment would restrict the mobility of AEDANS. The extent
of the fast mobility decrease should depend on both the
level of the steric hindrance and the initial rotational free-
dom of the AEDANSmoiety. Thus, to further study the inter-
action between 14-3-3 and dpPdc, we used the polarized
time-resolved emission measurements to examine the seg-
mental dynamics of the AEDANS-labeled Pdc mutants andBiophysical Journal 103(9) 1960–1969its changes upon phosphorylation and 14-3-3 protein
binding. The results of these measurements are also summa-
rized in Table 3 and Fig. 4. The observed emission anisotropy
decays were rather complex, exhibiting four classes of corre-
lation times. Short correlation times located near 500 ps and
3 ns reflect fast localmotion of theAEDANSgroup. The third
correlation time, f3, is likely related to the rotational diffu-
sion of large rigid domains of the Pdc molecule. The longest
correlation time, f4, can be assigned to the overall rotation
of the Pdc molecule. Due to the high local mobility of the
AEDANS moiety attached to the Pdc molecule causing
almost complete fast depolarization of the emission, rather
small-amplitude b4 remains for detection of the overall
molecular rotation. Together with an unavoidable trace
amount of slowly developing AEDANS-induced aggregates
present in our samples (~0.01–0.02 of b4) biasing f4 toward
larger values, this prevented us from determining f4 accu-
rately.We used overall change bshort¼ b1þ b2 in amplitudes
of fast anisotropy decay components belonging to a rapid
fluorophore motion as a measure of change in the segmen-
tal mobility of Pdc regions containing AEDANS-labeled
cysteine residues. It can be seen that the phosphorylation
by itself significantly increased the segmental mobility
(i.e., the flexibility) of Pdc(Cys157) and slightly increased
that of Pdc(Cys97) (Fig. 4 A). Little or no change in bshort
was observed for Pdc(Cys89), Pdc(Cys148), and Pdc
(Cys168). On the other hand, the 14-3-3 protein binding
reduced the flexibility of all labeled regions of dpPdc except
for dpPdc(Cys157), with the largest change observed for
mutants dpPdc(Cys89) and dpPdc(Cys168) (Fig. 4, Fig. S3,
and Fig. S4). Mutant dpPdc(Cys157) exhibited increased
FIGURE 4 Change in the mean excited-state lifetime, tmean, and the
overall change in amplitudes of fast anisotropy decay components
belonging to a rapid fluorophore motion (bshort ¼ b1 þ b2) of AEDANS
moieties attached at five different cysteine residues (Cys-89, Cys-97,
Cys-148, Cys-157, and Cys-168). (A) Changes induced by phosphorylation
of Pdc at Ser-54 and Ser-73. (B) Changes induced by the 14-3-3 protein
binding to phosphorylated dpPdc.
Structural Modulation of Phosducin by 14-3-3 1967segmental flexibility upon binding of 14-3-3. The changes in
the raw AEDANS fluorescence anisotropy decays of the
dpPdc(Cys168) mutant resulting from the interaction with
14-3-3 are shown in Fig. S3. Visual inspection of this figure
reveals that although the binding of 14-3-3 to the phosphor-
ylated dpPdc(Cys168) results in a highly significant change
in the decay data (Fig. S3 B), the phosphorylation of Ser-54
and Ser-73 by itself has only a minor effect on AEDANS
anisotropy decay (Fig. S3 A). The effect of the addition of
14-3-3 protein to the unphosphorylated Pdc(Cys168) is
shown in Fig. S3 C. Because the 14-3-3 protein does not
bind the unphosphorylated Pdc, the figure demonstrates the
reproducibility of the measured data and serves as a standard
for evaluating the observed changes in panels A and B.
Similar data quality was obtained for all measured mutants;
for example, Fig. S4 shows raw fluorescence anisotropy
decays of the AEDANS-labeled dpPdc(Cys89) mutant.
It can also be seen that changes in tmean and bshort have
the opposite trend, especially upon binding of the 14-3-3
protein to dpPdc (Fig. 4 B), suggesting a positive correlationbetween the segmental flexibility and the surface exposure
(or polarity) of labeled Pdc regions. Explicitly, an increase
of tmean indicates reduced AEDANS exposure to an aqueous
or polar microenvironment, which correlates nicely with
the decreased internal flexibility of the Pdc structure upon
binding of the 14-3-3 protein as quantified by bshort. Hence,
the AEDANS emission anisotropy decay measurements
reveal that binding of the 14-3-3 protein significantly affects
the structure of both domains of dpPdc, presumably through
direct physical contacts with various regions of the Pdc
molecule.DISCUSSION
Our goal in this work was to investigate as yet unresolved
details concerning the interaction between the phosphopro-
tein Pdc and the 14-3-3 protein. Retinal Pdc regulates G
protein signaling by competing with the Gta subunit for
binding to the Gtbg complex (1,2). The comparison of
in vitro and in vivo studies suggested that the phosphoryla-
tion of Pdc at Ser-54 and Ser-73 plays an essential role in
this process by initiating Pdc binding to the 14-3-3 protein
and thereby inhibiting the interaction between Pdc and
Gtbg through mechanisms that remain unclear (10,11,14).
Based on what is currently known about the function of
14-3-3 proteins, it is reasonable to speculate that the 14-3-
3 protein blocks the interaction between Pdc and the Gtbg
complex, for example, by sterically occluding the Gtbg
interaction surface of Pdc and/or by changing the Pdc struc-
ture (15). Our fluorescence spectroscopy measurements
suggest that the 14-3-3 protein interacts with several regions
within both domains of dpPdc. The N-terminal domain
constitutes the main part of Pdc’s interaction surface with
Gtbg (~65% of the total binding surface), as shown by the
crystal structure of the Pdc:Gtbg complex (8). The single
tryptophan residue that was used for tryptophan fluores-
cence experiments, Trp-29, is part of a conserved segment
located at the N-terminal end of helix 1 that makes extensive
interactions with Gtb (Fig. 1). Furthermore, two of five
cysteine residues that were modified by the extrinsic fluoro-
phore AEDANS, Cys-89 and Cys-97, are located within the
helix 3, which is also involved in contacts with Gtb (8). It is
likely that the observed changes in the fluorescence proper-
ties of the Trp-29 and AEDANS moieties (Figs. 3 A and 4 B;
Tables 2 and 3) are caused by steric shielding of the fluo-
rophore upon 14-3-3 protein binding or 14-3-3-binding-
induced structural changes, which suggests a physical
contact between 14-3-3 and labeled regions of dpPdc.
This is also consistent with the results of time-resolved
fluorescence anisotropy experiments that showed a restric-
tion of segmental motions of labeled regions upon binding
of the 14-3-3 protein to dpPdc. Our data, therefore, show
that 14-3-3 interacts with regions that are important parts
of Pdc’s binding surface for Gtbg, and thus suggest an
explanation for the inhibitory effect of the 14-3-3 bindingBiophysical Journal 103(9) 1960–1969
1968 Rezabkova et al.on Pdc’s interaction with Gtbg. The binding of 14-3-3 to the
N-terminal domain could also affect Pdc’s function and
cellular stability through modulation of its posttranslational
modification by the small ubiquitin-related modifier SUMO.
The Pdc SUMOylation site, Lys-33, lies in close vicinity
to Trp-29 (39), and thus in the region whose structure is
changed upon 14-3-3 binding.
The C-terminal domain of Pdc possesses the thioredoxin-
like fold and binds to Gtb in a manner that is likely to disrupt
Gtbg’s orientation relative to the membrane (8). It has also
been shown that this domain mediates interactions between
Pdc and its two other binding partners, SUG1 and CRX.
SUG1 is a subunit of the 26S proteasome, which may also
indirectly modulate transcription (26). CRX is the cone-rod
homeobox transcription factor that is expressed selectively
in retinal photoreceptors and pinealocytes (3). The functional
consequences of these interactions are still unknown, but it
has been speculated that SUG1 targets Pdc to the 26S protea-
some, where it is degraded. On the other hand, the interaction
between Pdc and CRXmay interferewith the CRX-mediated
gene transactivation (3). Time-resolved fluorescence mea-
surements of AEDANS-labeled dpPdc suggest either a direct
physical contact between the AEDANS moiety attached at
Cys-168 within the C-terminal domain and 14-3-3 and/or
a conformational change of this region induced by binding
of the 14-3-3 protein (Fig. 4 B and Table 3). Therefore, it is
reasonable to speculate that the 14-3-3 binding could modu-
late dpPdc’s interaction with CRX and SUG1.
It has been suggested that the N-terminal domain of Pdc is
highly flexible and disordered. Crystallographic studies re-
vealed this high flexibility especially in regions that do
not contact Gtbg (8,38). Moreover, both one-dimensional
proton NMR and circular dichroism experiments indicated
that the N-terminal domain of free Pdc (in the absence of
Gtbg) lacks any explicit native conformation (38). The
values of RH obtained for Pdc from DLS and time-resolved
tryptophan fluorescence that are significantly higher than
expected for a globular protein of the given molecular
mass, as well as the enhanced proteolytic sensitivity, sup-
port the disordered (and/or flexible) nature of this domain
(Table 1 and Fig. S2). The time-resolved emission anisot-
ropy decay measurements reveal that the 14-3-3 protein
binding reduces the flexibility of labeled regions within
both domains of dpPdc. This disorder-to-order transition
may be one of the reasons for the relatively low binding
affinity of dpPdc for the 14-3-3 protein (KD is in the
micrometer range), because the decrease in the configura-
tional entropy upon binding would have an unfavorable
effect on the binding affinity. In addition, the crystal struc-
ture of the complex between pPdc(pS73) and Gtbg showed
that the phosphorylation of Pdc at Ser-73 causes an order-
to-disorder transition of a 20-residue stretch including the
phosphorylation site. Consistently, our fluorescence spec-
troscopy measurements suggest that the phosphorylation
by itself affects the structure of both the N- and C-terminalBiophysical Journal 103(9) 1960–1969domains of Pdc, as documented by the increase in the
segmental flexibility of Trp-29 and changes in tmean of
AEDANS moieties attached at all five cysteine residues
(Tables 2 and 3; Fig. 4 A). Interestingly, the most profound
phosphorylation-dependent changes in fluorescence proper-
ties were observed for AEDANS moieties attached at Cys-
148 and Cys-157 within the C-terminal domain, although
both phosphorylation sites are located at the N-terminus
of Pdc (Fig. 1). This suggests that both domains of Pdc
interact with each other, possibly through the region that
includes both Cys-148 and Cys-157. Thus, a posttransla-
tional modification within the N-terminal domain can affect
the structure in the C-terminal domain.
In addition, the consecutive increase in segmental flexi-
bility upon phosphorylation (Fig. 4 A) and the consequent
binding of 14-3-3 protein (Fig. 4 B) was observed only for
the AEDANS-labeled Pdc(Cys157) mutant. The crystal
structure of the complex between Pdc and Gtbg revealed
that Cys-157 is located on the surface of the C-terminal
domain (8,9). We may speculate that in the unphosphory-
lated Pdc the segmental flexibility of the region containing
Cys-157 is reduced, presumably due to its interaction with
the N-terminal domain, and both phosphorylation and 14-
3-3 protein binding affect this interdomain interaction.CONCLUSIONS
The phosphorylation of the N-terminal domain of Pdc at
Ser-54 and Ser-73 affects the structure of the whole Pdc
molecule, suggesting that the N- and C-terminal domains
interact with each other. Phosphorylated Pdc and the 14-
3-3 protein form a stable complex with 1:2 molar stoichiom-
etry. Complex formation with 14-3-3 affects the structure
and reduces the flexibility of both the N- and C-terminal
domains of dpPdc, suggesting that dpPdc undergoes a con-
formational change when binding to 14-3-3. These changes
involve the Gtbg binding surface within the N-terminal
domain of dpPdc, and thus could explain the inhibitory
effect of 14-3-3 on Pdc function.SUPPORTING MATERIAL
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